Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ombrabulin + Cisplatin in Advanced Soft Tissue Sarcoma
NCT00699517Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of Ombrabulin in soft tissue sarcoma (STS), sponsored by Sanofi. Started Jun 2008; status: completed.
02
Drugs
Ombrabulin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00699517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699517.